Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (2): 235-240.
DOI: 10.19803/j.1672-8629.20230494
XIN Lingyi1,2, YANG Yang3, ZHU Jing1,2, HE Na1,2, ZHANG Jingmei1,2, WANG Hangtian1,2, CHEN Qinhua3, YANG Guangyi1,2,*
Received:
2023-08-16
Online:
2024-02-15
Published:
2024-02-06
CLC Number:
XIN Lingyi, YANG Yang, ZHU Jing, HE Na, ZHANG Jingmei, WANG Hangtian, CHEN Qinhua, YANG Guangyi. Classification of anti-tumor active ingredients of Paridis Rhizoma and research progress in mechanisms of action[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 235-240.
[1] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[S]. Beijing: China Medical Science Press, 2020: 271. [2] PENG LF, ZHANG XN, FENG LP, et al.Identification and content determination of fibrillar diosgenin in paris vietnamensis[J].China Pharmacy(中国药房), 2015, 26(3): 384-386. [3] MIMAKI Y, SASHIDA Y.Steroidal and phenolic constituents of Lilium speciosum[J]. Phytochemistry, 1991, 30(3): 937-940. [4] WANG Y, FAN Q, XIANG J, et al.Structural characterization and discrimination of Paris polyphylla var. yunnanensis by a molecular networking strategy coupled with ultra-high-performance liquid chromatography with quadrupole time-of-flight mass spectrometry[J]. Rapid Commun Mass Spectrom, 2020, 34(11): e8760. [5] ZHANG X, WU J, QIN L, et al.Separation and purification of two saponins from paris polyphylla var. yunnanensis by a macroporous resin[J]. Molecules, 2022, 27(19): 6626. [6] HU JM, TANG HF, LU YY, et al.A new cyclic cholestanol-type steroidal saponin from Narrow-leafed Serpentine saponins[J]. Central South Pharmacy(中南药学), 2022, 20(4): 736-743. [7] CUI Y.Studies on the chemical structure of some active components of the Chinese traditional medicine [8] GAO X, ZHANG X, CHEN W, et al.Transcriptome analysis of Paris polyphylla var. yunnanensis illuminates the biosynthesis and accumulation of steroidal saponins in rhizomesandleaves[J]. Phytochemistry, 2020, 178: 112460. [9] LIU W, CHAI Y, HU LB, et al.Polyphyllin VI induces apoptosis and autophagy via reactive oxygen species mediated JNK and P38 activation in glioma[J]. Onco Targets Ther, 2020, 13: 2275-2288. [10] YANG L, ZHU T, Ye H, et al.Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway[J]. J Cell Mol Med, 2021, 25(2): 801-812. [11] SHEN ZC, SHEN JH, XIE XX, et al.Effects of polyphylla var. Yunnanensis saponins on cell cycle and apoptosis in prostate cancer cells[J]. Journal of Modern Urology(现代泌尿外科杂志), 2021, 26(10): 867-872. [12] LAI L, SHEN Q, WANG Y, et al.Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling[J]. Toxicology and Applied Pharmacology, 2021, 419: 115518. [13] ZHU X, NA X, ZENG Y, et al.Polyphyllin I combined with doxorubicin shows chemosensitization effect [14] WU Y, SI Y, XIANG Y, et al.Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy[J]. Arch Biochem Biophys, 2020, 687: 108285. [15] HAN J, KAN J, WANG X, et al.Polyphyllin I suppresses proliferation and promotes apoptosis of gastric cancer cell by inhibiting stat3 phosphorylation[J]. Translational Cancer Research, 2020, 9(8): 4715. [16] TANG Q, WANG SM, WU WK, et al.Inhibitory effect of Polyphyllin I regulating Sp1/miR-542-3p/ILK signaling pathway on lung cancer cells[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2022, 37(5): 2805-2812 [17] LUO Q, JIA L, HUANG C, et al.Polyphyllin I Promotes autophagic cell death and apoptosis of colon cancer cells via the ros-inhibited AKT/mTOR pathway[J]. International Journal of Molecular Sciences, 2022, 23(16): 9368. [18] LIU MM, ZHU ML, DONG RF, et al.Polyphyllin I promotes cell death via suppressing UPR-mediated CHOP ubiquitination and degradation in non-small cell lung cancer[J]. Chinese Journal of Natural Medicines(中国天然药物), 2021, 19(4): 255-266. [19] JIA P, LONG FR, WANG LF, et al.Exploring the anti-ovarian cancer effects of rehmannia Polyphyllin I based on epigenetic regulation of [20] NIU W, XU L, LI J, et al.Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs[J]. Oncol Lett, 2020, 20(3): 2928-2936. [21] GAO J.Regulation of PI3K/Akt signaling pathway by polyphyllin II induces autophagy and anti-tumor angiogenesis in melanoma B16F10 cells[D]. Hefei: Anhui University of Chinese Medicine, 2021. [22] SHANGGUAN WJ, YU P, QIAN FF, et al.Polyphyllin VII induces apoptosis in lung adenocarcinoma circulating tumor cell clusters through DNA damage-mediated p53 signaling pathway[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2022, 42(7): 849-855. [23] WANG LW, XU Q, SUN YH.Inhibition of proliferation and induction of apoptosis by polyphyllin VII in human colon cancer cell lines[J]. China Medicine(中国医药), 2020, 15(1): 92-95. [24] MA P, CAO TT, LIU D, et al.Studies on the [25] ZHAO X, XU L, ZHENG L, et al.Potent effects of dioscin against gastric cancer in vitro and in vivo[J]. Phytomedicine(植物医学), 2016, 23(3): 274-282. [26] ZHANG W, LIN L, ZHANG Y, et al.Dioscin potentiates the antitumor effect of suicide gene therapy in melanoma by gap junction intercellular communication-mediated antigen cross-presentation[J]. Biomedicine & Pharmacotherapy, 2022, 150: 112973. [27] WANG X, ZHANG R, WANG S, et al.Development, characterisation, and [28] SHEN Z, WANG J, KE K, et al.Polyphyllin I, a lethal partner of Palbociclib, suppresses non-small cell lung cancer through activation of p21/CDK2/Rb pathway [29] DENG B.Effects of total saponin from Rhizoma Paris on proliferation and radiosensitivity of human hepatocellular carcinoma HepG2 cells[D]. Wuhan: Hubei University of Chinese Medicine, 2018. [30] ZHANG L, XIONG YL, REN YL, et al.Mechanism of action of polyphyllin A directly targeting ETS-1 to inhibit proliferation and induce apoptosis in gastric cancer cells[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2022, 47(6): 1650-1657. [31] LI X, SU DH, GAO XM, et al.Rhizoma paris saponin promotes iron death in triple-negative breast cancer cells via the p53/SLC7A11 axis[J]. Med J Chin PLA(解放军医学杂志), 2023, 48(1): 58-63. [32] SUN GQ, XUE YY, LU YY, et al.Induction of apoptosis and pyroptosis in temozolomide-resistant glioma SHG44R cells by polyphyllin H[J]. Central South Pharmacy(中南药学), 2022, 20(5): 973-978. [33] LIU Y, CAO Y, KAI H, et al.Polyphyllin E inhibits proliferation, migration and invasion of ovarian cancer cells by down-regulating the AKT/NF- [34] WANG H, HAN H, XU Y, et al.A simple and sensitive LC-MS/MS method for the determination of polyphyllin VII in rat plasma and its application to pharmacokinetic study[J]. Biomedical Chromatography, 2023, 37(5): e5597. [35] LIU ZY, WANG BF, LI D, et al.Extraction of polyphyllin and its pharmacokinetics in rats[J]. Chinese Journal of Laboratory Diagnosis(中国实验诊断学), 2016, 20(10): 1640-1643. [36] WANG G, HAO R, LUO C, et al.Pharmacokinetics profiles of polyphyllin II and polyphyllin VII in rats by liquid chromatography with tandem mass spectrometry[J]. Biomedical Chromatography, 2021, 35(6): e5083. [37] Ministry of Health of the People’s Republic of China. Traditional Chinese Medicine Formulations(中药成方制剂)[S]. Beijing: National Health Commission of the People’s Republic of China, 1989. [38] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China - Clinical Medication Instructions(中华人民共和国药典临床用药须知)[M]. Beijing: China Hospital Science Press, 2015. [39] ZHANG WJ.A brief experience on the treatment of malignant tumors by beehives with Paridis Rhizoma[J]. Renowned Doctor(名医), 2019(2): 133. [40] XU SY, YANG XY, JIA ML, et al. Overview of the application of GongXueNingJiaoNang in gynecological diseases in the past 5 years[J]. World Latest Medicine Information(世界最新医学信息文摘), 2017, 17(54): 77, 79. [41] GUO SY, YIN Y, LEI T, et al.A cycloartenol synthase from the steroidal saponin biosynthesis pathway of Paris polyphylla[J]. Journal of Asian Natural Products Research, 2021, 23(4): 353-362. [42] XIAO WH, YANG ZW, LI Y.Analysis of the cytotoxicity of polyphyllin I on human erythrocytes in vitro based on three-dimensional morphology of single cell[J]. Chinese Journal of Blood Transfusion(中国输血杂志), 2019, 32(4): 334-338. [43] WANG WP.Evaluation of the toxicity of Paris Saponin I,Ⅱ and Ⅶ and investigation of the mechanism of hepatotoxicity of Paris Saponin I[D]. Beijing: Beijing University of Chinese Medicine, 2022. [44] WANG X, CHEN LZ, LIN RC, et al.Developmental toxicity and anti-neovascularization activity of polyphyllin I on zebrafish and its mechanisms[J]. Chinese Traditional and Herbal Drugs(中草药), 2023, 54(14): 4548-4555. [45] CHEN XM, YANG HZ, SI M, et al.Study on the antitumor activity and acute toxicity of total saponins of Paris forrestii[J]. Drug Evaluation Research(药物评价研究), 2017, 40(7): 904-910. [46] LIU Y, LIU MY, BI LL, et al.Cytotoxic steroidal glycosides from the rhizomes of Paris polyphylla var. yunnanensis[J]. Phytochemistry, 2023, 207: 113577. [47] ZHANG T, ZHANG L, LU JF, et al.Mechanism of polyphyllinⅠtargeting EGFR to affect proliferation and apoptosis of human breast cancer cells[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2022, 47: 721-729. [48] ZHANG L,XIONG YL,REN YL et al. Mechanism of polyphyllin A in inhibition of proliferation and induction of apoptosis of gastric cancer cells by directly targeting ETS-1[J] . China Journal of Chinese Materia Medica(中国中药杂志), 2022, 47: 1650-1657. [49] NIU WP, X U LL, JING W, et al. Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs[J]. Oncol Lett, 2020, 20: 2928-2936. [50] WANG Y, HUANG XL, XIAN B, et al.Paris polyphylla Machine learning and bioinformatics-based insights into the potential targets of saponins in smith against non-small cell lung cancer[J]. Front Genet, 2022, 13: 1005896. [51] ZHANG C, LI QR, QIN GZ, et al.Anti-angiogenesis and anti-metastasis effects of Polyphyllin VII on hepatocellular carcinoma cells [52] CHEN PS, SHIH YW, HUANG HC, et al.Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression[J]. PLos One, 2011, 6(5): e20164. [53] YEN ML, SU JL, CHIEN CL, et al.Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts[J]. Mol Pharmacol, 2005, 68(4): 1061-1073. |
[1] | XIE Rui, GENG Zihan, BAO Lei, ZHAO Ronghua, LI Shuran, SUN Qiyue, WANG Xinwei, ZHANG Jingsheng, CUI Xiaolan, GUO Shanshan, SUN Jing. Research Progress in Pharmacological Actions, Mechanisms, Structural Modifications and Targeted Formulations of Ribavirin [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 950-955. |
[2] | WANG Yinghe, LI Mingqi, ZHAO Xiaolu, MA Yuehong. Different Functions of Autophagy in Diseased Livers [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 956-960. |
[3] | LIU Ming, ZHENG Li, ZHANG Weina, SUN Xuelin, TIAN Jinhui, ZHAO Yan. Research Progress in Biological Activity and Mechanisms of Pachymic Acid [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 826-830. |
[4] | ZHONG Xinru, YANG Deying, GUAN Tangming, CHEN Ju, JIANG Dongbo. Research Progress in Adverse Reactions Caused by Obinutuzumab in the Treatment of Follicular Lymphoma [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 831-835. |
[5] | GAO Caiyun, WANG Boyuan, GAO Xiaojie. Research Progress in Correlations between SGLT2 Inhibitors and Malignant Tumors [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 836-840. |
[6] | CUI Mengyao, LI Shuran, XIE Dan, YANG Xiaowei, LIU Xian, CUI Xiaolan, GENG Zihan, GUO Shanshan. Research Progress in Antiviral Targets and Active Ingredients of Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 481-487. |
[7] | CAO Weiping, ZHANG Shichao, NI Xia, XIE Bing, WANG Xinzhi, XING Mengtao. Research Progress in Liver Injury Caused by Drugs Commonly Used during Pregnancy [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 528-531. |
[8] | SONG Zhongxu, HU Jiaojiao, JIN Yan, ZHAO Yuyang, TIAN Hui, YUAN Yuan. Evaluation and Selection of Antitumor Activity of Sixteen Zhuang Toxic Medicinal Materials [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 539-546. |
[9] | BU Zixuan, XUE Mengwei, TIAN Jiawei, KE Kaile, WANG Ziying, LI Xiao, LU Tiangong. Interventions of Guizhi Fuling Pills in Properties of Ovarian Cancer Stem Cells [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 263-270. |
[10] | TANG Qianhui, ZHANG Haoran, ZHANG Luyong, JIANG Zhenzhou. Research Progress in Triptolide-Induced Live Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 121-127. |
[11] | ZAN Ke, CAI Xisheng, WU Yun, WANG Zhao, WANG Dandan, LI Hailiang, JIN Hongyu. Six Active Ingredients in Medicinal and Non-Medicinal Parts of Farfarae Flos: a Comparative Study [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 67-71. |
[12] | PEI Yusheng, XU Lin, ZHAO Yuxin, CAI Tong, HUA Xiaodong. Low Endotoxin Recovery and Mitigation Strategies [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 72-75. |
[13] | LIU Lianqi, XIAO Dian, ZHONG Wu, ZHOU Xinbo, LI Song. Toxicity associated with antibody-drug conjugates and corresponding research strategies [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 721-729. |
[14] | GAO Haiyun, LI Yao, CHEN Yuxin, LI Hui, LIU Tianrui, YUAN Yuan. Research progress in pharmacology and safe use of Boletus edulis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 507-512. |
[15] | LI Xinlei, GONG Leilei, WANG Xiaoxia, ZHANG Xueyan, ZHAO Han, YAO Weijie, YUAN Sisi, FENG Xin. Molecular mechanism of Yangxue Antai granules for the treatment of recurrent spontaneous abortion based on network pharmacology and molecular docking [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 366-370. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||